Science Current Events | Science News | Brightsurf.com
 

HIV Transmission Current Events | HIV Transmission News | 6

Sort By: Page Views | Date
MU scientists 'see' how HIV matures into an infection
After improving the sensitivity of nuclear magnetic resonance (NMR), researchers at the University of Missouri actually watched the HIV-1 protease mature from an inactive form into an active infection. This process has never been directly visualized before. The findings appear today in the journal... view more (2008-10-02)

Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert researchers from the Harvard School of Public Health (HSPH) in a study published online by the Journal of Acquired Immune... view more (2008-10-21)

African HIV Subtypes Identified in Minnesota Population
Public health researchers in Minnesota recently identified 83 persons infected with subtypes of HIV-1 that are not common in the United States, according to a report published in the June 15 issue of The Journal of Infectious Diseases, now available online.   view more (2005-05-31)

nvestment Level in HIV Prevention Programs Related to HIV Incidence in the United States
Researchers at Johns Hopkins Bloomberg School of Public Health conducted a historical analysis to examine the relationship between the Centers for Disease Control and Prevention's (CDC) HIV prevention budget and HIV incidence in the U.S. from 1978 to 2006.   view more (2007-01-31)

Study highlights risky behavior, lack of care among HIV-infected crack users
Doctors who treat HIV-infected crack users refer to them as "the forgotten population." A study being presented at this week's International AIDS Conference in Mexico City reveals that these patients frequently lack outpatient health care, do not receive life-saving antiretroviral therapy... view more (2008-08-05)

HIV's effect on white blood cells questioned by new research
Scientists have refuted a longstanding theory of how HIV slowly depletes the body's capacity to fight infection, in new research published today.   view more (2007-05-22)

Pediatric HIV: Oral lesions are commonly associated with the disease
Across the globe, the presence of HIV is wide-spread. At the end of 2004, the United Nations HIV/AIDS program estimated that 2.5 million children under the age of 15 were affected worldwide.   view more (2006-10-09)

NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National... view more (2008-08-28)

When should children infected with HIV start medication
The advent of effective medications for treating HIV dramatically improved the outlook for both adults and children infected with HIV who had access to treatment, but the optimal timing for starting treatment remains controversial, particularly in children.   view more (2008-03-25)

Higher HIV infection estimate shows need for routine screening, more funding for care
The Centers for Disease Control and Prevention (CDC) is expected soon to increase the estimate of new HIV infections in the United States by 40 percent. This highlights the need to make HIV testing a routine part of medical care and provide better funding to care for those who test positive,... view more (2008-08-04)

HIV infection requires an accomplice: B cells with special protein direct HIV to T cells
HIV infection of T cells requires activation of a molecule on the surface of B cells, a finding that reveals yet another pathway the virus uses in its insidious attack on the immune system.   view more (2006-08-14)

Hopkins joins Ugandan researchers to study pediatric AIDS vaccine
Scientists at Makerere University, in Kampala, Uganda, along with scientists from Johns Hopkins and other institutions worldwide, have begun the first clinical safety trial in Africa of a vaccine to prevent mother-to-child transmission of HIV through breastfeeding.   view more (2006-10-13)

Tuberculosis Still a Risk for Patients Receiving HIV Drugs
People taking highly active antiretroviral therapy (HAART) for HIV infection remain susceptible to tuberculosis, though the risk is lower than for HIV-infected patients not on HAART.   view more (2005-11-14)

Hope: An overlooked tool in the battle against HIV/AIDS
The links between HIV transmission and the degree to which people are able to adopt realistic plans to achieve future projects, in other words, hope, have been overlooked in policies to tackle HIV/AIDS. New research funded by the Economic and Social Research Council (ESRC) argues that hope is a... view more (2008-08-11)

'POZ parties' signal potential to spread HIV 'superinfection'
The emergence of "POZ Parties"-parties exclusively for HIV positive men to meet other HIV positive men for sex-signals the potential to spread HIV "superinfection,"suggests research in Sexually Transmitted Infections.   view more (2005-09-29)

Cytomegalovirus infection still associated with poor HIV/AIDS prognosis (p 2101, 2116)
Results of a UK study in this week's issue of THE LANCET highlight how the treatment of cytomegalovirus infection remains a priority in order to improve the prognosis for people with HIV-1 infection, including people already receiving antiretroviral therapy. The advent of highly active... view more (2004-06-23)

Having a stable partner delays AIDS in HIV patients
For people with HIV, having a stable partner is associated with slower rate of progression to AIDS or death, finds a study in this week's BMJ. Researchers in Switzerland followed 3,736 adults with HIV who had started highly active antiretroviral therapy (HAART) before 2002. Every six months,... view more (2004-01-03)

Study suggests life insurance should cover people treated for HIV (p 877)
Issue 13 September 2003 Embargoed 0001 h (London time) 12 September 2003. Authors of a Swiss study in this week's issue of THE LANCET highlight how people effectively treated for HIV-1 infection with highly active antiretroviral therapy (HAART) have similar or lower mortality rates than patients... view more (2003-09-10)

Involving partners of pregnant women in Africa to improve AIDS prevention
According to the World Health Organization, nearly three-quarters of the world's 40 million human immunodeficiency virus (HIV)-infected people are living in Sub-Saharan Africa.   view more (2008-04-29)

Routine HIV screening in the ED is cost effective and well liked by patients
Using the new and highly publicized CDC guidelines for HIV screening, a university-based Emergency Department implemented opt-out screening in Washington, DC, where HIV infection rates are known to be high.   view more (2007-05-16)

Risk of fracture is significantly higher in HIV-infected patients
As antiviral treatment for HIV infection allows patients to live longer, many will be confronted with additional health challenges. A new study shows for the first time that one of these may be significantly increased risk of bone fractures.   view more (2008-08-29)

Three out of four junior doctors risk potential HIV infection during course of work
Three out of four junior doctors are at potentially high risk of HIV infection at some time during their careers, shows a survey in Sexually Transmitted Infections. Yet two thirds were unaware that they could be treated immediately afterwards to minimise the risk of infection.   view more (2001-11-20)

Viral 'fitness' explains different resistance patterns to aids drugs
Some HIV medications lead to the development of drug-resistant HIV when patients take as few as two percent of their medications.   view more (2006-01-11)

HIV isolate from Kenya provides clues for vaccine design
Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center published in PLoS Medicine.   view more (2008-01-03)

Delay in use of nevirapine-based AIDS treatment can improve outcomes
Delaying the use of nevirapine-containing antiretroviral therapy (ART) for at least six months after labor may improve treatment outcomes among HIV-infected women in developing countries who took nevirapine during labor to prevent their babies from becoming infected, suggests a new study in The New... view more (2007-01-11)

Sort By: Page Views | Date
© 2008 BrightSurf.com